Peptide-based drug design using generative AI

Key Points

• Peptide-based drugs demonstrate enhanced stability, indicating better performance in clinical applications.
• Key evidence highlights improvements in drug design through advancements in AI, particularly in peptide stability.
• Generative AI facilitates innovative drug design, focusing on enhancing peptide stability and specificity.
• Findings suggest that AI's role in peptide-based drug design may lead to more effective clinical treatments.

Abstract